Product Description: Lifibrol is a potent and oral activity hypolipidemic agent. Lifibrol decreases the plasma total cholesterol. Lifibrol has the potential for the research of hypercholesterolemia[1][2].
Formula: C21H26O4
References: [1]Locker PK, et al. Lifibrol: a novel lipid-lowering drug for the therapy of hypercholesterolemia. Lifibrol Study Group. Clin Pharmacol Ther. 1995 Jan;57(1):73-88. /[2]Bell FP, et al. Action of the new hypolipidemic agent lifibrol (K12.148) on lipid homeostasis in normal rats: plasma lipids, hepatic sterologenesis, and the fate of injected [14C]acetate. Lipids. 1993 Dec;28(12):1079-85.
CAS Number: 96609-16-4
Molecular Weight: 342.43
Research Area: Metabolic Disease
Solubility: 10 mM in DMSO
Target: Others